MedTrace Logo

Safety Planning and Cognitive Behavioral Therapy for Adolescent Suicide Prevention in Mozambique

NCT06465381 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2100

Last updated 2025-12-05

No results posted yet for this study

Summary

This implementation research project aims to test the effectiveness and implementation outcomes of suicide safety planning along and a transdiagnostic cognitive behavioral intervention for suicide prevention on decreasing suicidal behaviors in secondary school students in Mozambique. This study will also result in hypothesized mechanisms of intervention effects, costs and cost-effectiveness.

Conditions

  • Suicide Prevention

Interventions

BEHAVIORAL

Safety Planning Intervention

All behavioral interventions will be provided by a trained nonspecialist healthcare worker, descriptions of each intervention can be found under treatment arm/group descriptions.

BEHAVIORAL

Enhanced Usual Care

All behavioral interventions will be provided by a trained nonspecialist healthcare worker, descriptions of each intervention can be found under treatment arm/group descriptions.

BEHAVIORAL

Transdiagnostic Cognitive Behavioral Therapy for Suicide Prevention

All behavioral interventions will be provided by a trained nonspecialist healthcare worker, descriptions of each intervention can be found under treatment arm/group descriptions.

Sponsors & Collaborators

Principal Investigators

  • Bradley Wagenaar, PhD, MPH · University of Washington

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-09-01
Primary Completion
2027-12-01
Completion
2028-12-01

Countries

  • Mozambique

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06465381 on ClinicalTrials.gov